𝛼SK or Searchbullish
Artrya (AYA.ASX): HCA Midwest Health joins SAPPHIRE study - approaching 400,000 annual scan target
SUMMARY
- Artrya announced that HCA Midwest Health has agreed to “in-principle participation” in the SAPPHIRE study.
- HCA Midwest Health is one of 15 divisions of HCA Healthcare, the largest for-profit healthcare system in the US.
- HCA Midwest Health is a world-renowned cardiovascular research hub, and its participation is hugely positive for SAPPHIRE, Salix and Artrya, providing them not only with credibility but also an entryway to securing HCA as a commercial customer.
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- Artrya (AYA.ASX): HCA Midwest Health joins SAPPHIRE study - approaching 400,000 annual scan target08 Feb 2026
x